Home Tags Has announced it has completed a financing round which raised US$23 million (A$34 million) in new funds.
Tag: has announced it has completed a financing round which raised US$23 million (A$34 million) in new funds.
Vaxxas raises $34 million to clinically advance needle-free vaccines, including a next-generation COVID-19 vaccine...
Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, has announced it has completed a financing round which raised US$23 million (A$34 million) in new funds.
Featured Article
Beyond Insights: Building trust into digital transformation technologies
Digital transformation technologies are experiencing a gold rush in the manufacturing industry, not just in Australia but beyond. However, amid this surge in cutting-edge tech and automation processes, a fundamental element remains crucial: trust.
